Innovation and the pharmaceutical industry: critical reflections on the virtues of profit
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Salem, MA
M & M Scrivener Press
c2008
|
| Schriftenreihe: | Conflicts and trends
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | viii, 245 p |
| ISBN: | 9780980209440 0980209447 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044105793 | ||
| 003 | DE-604 | ||
| 005 | 20180623 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9780980209440 |c hardcover : alk. paper |9 978-0-9802094-4-0 | ||
| 020 | |a 0980209447 |c hardcover : alk. paper |9 0-9802094-4-7 | ||
| 035 | |a (ZDB-30-PAD)EBC3340016 | ||
| 035 | |a (ZDB-89-EBL)EBL3340016 | ||
| 035 | |a (OCoLC)328405525 | ||
| 035 | |a (DE-599)BVBBV044105793 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 338.4/791510973 |2 22 | |
| 245 | 1 | 0 | |a Innovation and the pharmaceutical industry |b critical reflections on the virtues of profit |c edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett |
| 264 | 1 | |a Salem, MA |b M & M Scrivener Press |c c2008 | |
| 300 | |a viii, 245 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Conflicts and trends | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Medical innovations | |
| 650 | 4 | |a Medical policy |z United States | |
| 650 | 4 | |a Drugs |x economics |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Engelhardt, Hugo Tristram |d 1941-2018 |e Sonstige |0 (DE-588)119132419 |4 oth | |
| 700 | 1 | |a Garrett, Jeremy R. |d 1977- |e Sonstige |0 (DE-588)1031693300 |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-9802094-4-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-9802094-4-7 |
| 912 | |a ZDB-30-PAD |a ZDB-30-PBE | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-029512638 | |
Datensatz im Suchindex
| _version_ | 1807958507915313152 |
|---|---|
| adam_text | |
| any_adam_object | |
| author_GND | (DE-588)119132419 (DE-588)1031693300 |
| building | Verbundindex |
| bvnumber | BV044105793 |
| collection | ZDB-30-PAD ZDB-30-PBE |
| contents | Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis |
| ctrlnum | (ZDB-30-PAD)EBC3340016 (ZDB-89-EBL)EBL3340016 (OCoLC)328405525 (DE-599)BVBBV044105793 |
| dewey-full | 338.4/791510973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/791510973 |
| dewey-search | 338.4/791510973 |
| dewey-sort | 3338.4 9791510973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000zc 4500</leader><controlfield tag="001">BV044105793</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180623</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780980209440</subfield><subfield code="c">hardcover : alk. paper</subfield><subfield code="9">978-0-9802094-4-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0980209447</subfield><subfield code="c">hardcover : alk. paper</subfield><subfield code="9">0-9802094-4-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3340016</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3340016</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)328405525</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044105793</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/791510973</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Innovation and the pharmaceutical industry</subfield><subfield code="b">critical reflections on the virtues of profit</subfield><subfield code="c">edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Salem, MA</subfield><subfield code="b">M & M Scrivener Press</subfield><subfield code="c">c2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 245 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Conflicts and trends</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engelhardt, Hugo Tristram</subfield><subfield code="d">1941-2018</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)119132419</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garrett, Jeremy R.</subfield><subfield code="d">1977-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1031693300</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-9802094-4-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-9802094-4-7</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield><subfield code="a">ZDB-30-PBE</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029512638</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV044105793 |
| illustrated | Not Illustrated |
| indexdate | 2024-08-21T01:26:33Z |
| institution | BVB |
| isbn | 9780980209440 0980209447 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029512638 |
| oclc_num | 328405525 |
| open_access_boolean | |
| physical | viii, 245 p |
| psigel | ZDB-30-PAD ZDB-30-PBE |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | M & M Scrivener Press |
| record_format | marc |
| series2 | Conflicts and trends |
| spelling | Innovation and the pharmaceutical industry critical reflections on the virtues of profit edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett Salem, MA M & M Scrivener Press c2008 viii, 245 p txt rdacontent c rdamedia cr rdacarrier Conflicts and trends Includes bibliographical references and index Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis Pharmaceutical industry Drug development Medical innovations Medical policy United States Drugs economics United States USA Engelhardt, Hugo Tristram 1941-2018 Sonstige (DE-588)119132419 oth Garrett, Jeremy R. 1977- Sonstige (DE-588)1031693300 oth Erscheint auch als Druck-Ausgabe, Hardcover 978-0-9802094-4-0 Erscheint auch als Druck-Ausgabe, Hardcover 0-9802094-4-7 |
| spellingShingle | Innovation and the pharmaceutical industry critical reflections on the virtues of profit Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis Pharmaceutical industry Drug development Medical innovations Medical policy United States Drugs economics United States |
| title | Innovation and the pharmaceutical industry critical reflections on the virtues of profit |
| title_auth | Innovation and the pharmaceutical industry critical reflections on the virtues of profit |
| title_exact_search | Innovation and the pharmaceutical industry critical reflections on the virtues of profit |
| title_full | Innovation and the pharmaceutical industry critical reflections on the virtues of profit edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett |
| title_fullStr | Innovation and the pharmaceutical industry critical reflections on the virtues of profit edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett |
| title_full_unstemmed | Innovation and the pharmaceutical industry critical reflections on the virtues of profit edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett |
| title_short | Innovation and the pharmaceutical industry |
| title_sort | innovation and the pharmaceutical industry critical reflections on the virtues of profit |
| title_sub | critical reflections on the virtues of profit |
| topic | Pharmaceutical industry Drug development Medical innovations Medical policy United States Drugs economics United States |
| topic_facet | Pharmaceutical industry Drug development Medical innovations Medical policy United States Drugs economics United States USA |
| work_keys_str_mv | AT engelhardthugotristram innovationandthepharmaceuticalindustrycriticalreflectionsonthevirtuesofprofit AT garrettjeremyr innovationandthepharmaceuticalindustrycriticalreflectionsonthevirtuesofprofit |